Search Results - "Vartanov, Alexander R"
-
1
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Published in The New England journal of medicine (29-12-2011)“…CLL is a heterogeneous disease with a variable clinical course and response to therapy. New genetic lesions have been noted in subgroups of patients through…”
Get full text
Journal Article -
2
Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19
Published in Curēus (Palo Alto, CA) (26-02-2022)“…The coronavirus disease 2019 (COVID-19) global pandemic has put an unprecedented strain on cancer care. The initial months were marred by fears of…”
Get full text
Journal Article -
3
Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia
Published in JAMA dermatology (Chicago, Ill.) (01-03-2014)“…Although it has been well established that patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing skin cancer, few studies have…”
Get more information
Journal Article -
4
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL
Published in Blood (14-08-2014)“…One major goal of cancer genome sequencing is to identify key genes and pathways that drive tumor pathogenesis. Although many studies have identified candidate…”
Get full text
Journal Article -
5
Ofatumumab plus high dose methylprednisolone followed by ofatumumab plus alemtuzumab to achieve maximal cytoreduction prior to allogeneic transplantation for 17p deleted or TP53 mutated chronic lymphocytic leukemia
Published in Leukemia & lymphoma (16-04-2019)“…We hypothesized that ofatumumab with sequential methylprednisolone - alemtuzumab would be an effective and tolerable regimen for patients with high-risk…”
Get full text
Journal Article -
6
A Comparative Analysis of Engraftment Outcomes for Recipients of Allogeneic Hematopoietic Stem Cell Transplants (allo HSCT) and Post-Transplant Cyclophosphamide (PTCy) Based on Ideal Body Weight (IBW) or Actual Body Weight (ABW) Dosing of CD34-Positive Stem Cells
Published in Transplantation and cellular therapy (01-02-2024)“…Previous studies have demonstrated that CD34+ cell doses using IBW are more predictive of engraftment than ABW, with 2 × 106 CD34 cells/Kg of IBW established…”
Get full text
Journal Article -
7
Mass Cytometry Identifies T Cell Populations Associated with Severe Hepatotoxicity in CLL Patients on Upfront Idelalisib
Published in Blood (29-11-2018)“…Introduction Phosphatidylinositol-3-kinase (PI3K) inhibition has emerged as a novel targeted mechanism for achieving durable remission in CLL in both the…”
Get full text
Journal Article -
8
High Sensitivity NGS Analysis of MRD in CLL Patients Prospectively Treated with Ibrutinib Plus FCR (iFCR)
Published in Blood (13-11-2019)“…Background Studies from the chemoimmunotherapy (CIT) era and more recently with venetoclax have demonstrated the correlation between minimal residual disease…”
Get full text
Journal Article -
9
Imbalance in T Cell Subsets Triggers the Autoimmune Toxicity of PI3K Inhibitors in CLL
Published in Blood (13-11-2019)“…Idelalisib and duvelisib are FDA approved oral inhibitors of PI3K delta and PI3K delta/gamma, respectively. Previously, we reported a decrease in regulatory T…”
Get full text
Journal Article -
10
Using Oral Vancomycin As Prophylaxis Against Clostridioides Difficile Infection in Stem Cell Transplant Recipients Is Associated with Increased Gram Negative Bacteremia
Published in Transplantation and cellular therapy (01-02-2024)“…Infections complications continue to pose significant risk for patients undergoing hematopoietic stem cell transplantation (HSCT). Clostridioides difficile…”
Get full text
Journal Article -
11
High-grade heart block associated with ibrutinib therapy
Published in HeartRhythm case reports (01-06-2021)Get full text
Journal Article -
12
Whole Genome Sequencing of Indolent CLL Reveals Novel Structural Rearrangements
Published in Blood (06-12-2014)“…Several recent next generation sequencing studies have uncovered mutations in key genes that contribute to CLL pathogenesis. Most CLLs with deletions of…”
Get full text
Journal Article -
13
Rearrangement of 14q32 in the Absence of t(14;18) Is Associated with Short Time to First Treatment in Chronic Lymphocytic Leukemia
Published in Blood (18-11-2011)“…Abstract 1438 The hierarchical cytogenetic classification for chronic lymphocytic leukemia (CLL) provides a valuable prognostic framework validated in several…”
Get full text
Journal Article -
14
Prior Treatment with Chemotherapy Is Associated with Poor Outcomes of High Risk Skin Cancers in Patients with Chronic Lymphocytic Leukemia
Published in Blood (16-11-2012)“…Abstract 3920 The increased incidence of skin cancer in patients with chronic lymphocytic leukemia (CLL) has been well-documented; however, the outcomes for…”
Get full text
Journal Article -
15
Effect Of MYD88 Mutation In CLL On IRAK4 and BTK Inhibition In Vitro
Published in Blood (15-11-2013)“…Recent work in CLL and other lymphoproliferative disorders has established the importance of somatic mutations in the pathogenesis and prognosis of disease…”
Get full text
Journal Article -
16
NF-κB Pathway Mutations Modulate Cell Survival and Ibrutinib Response In Chronic Lymphocytic Leukemia
Published in Blood (15-11-2013)“…Constitutive activation of the NF-κB pathway is a critical feature of hematologic malignancies and is associated with increased lymphocyte proliferation and…”
Get full text
Journal Article -
17
Functional Somatic and Germline Variants in the NF-κB Pathway in Chronic Lymphocytic Leukemia
Published in Blood (16-11-2012)“…Abstract 560 Nuclear factor kappa B (NF-κB) encompasses a family of transcription factors involved in oncogenic processes including cellular proliferation and…”
Get full text
Journal Article -
18
Somatic and Germline Copy Neutral Loss of Heterozygosity Are Common in Chronic Lymphocytic Leukemia
Published in Blood (16-11-2012)“…Abstract 4567 Chronic lymphocytic leukemia (CLL) is the most common leukemia of adults, and prognosis is still difficult to predict, although cytogenetic…”
Get full text
Journal Article -
19
The Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Published in Blood (16-11-2012)“…Abstract 5 The impact of clonal heterogeneity on cancer progression in chronic lymphocytic leukemia (CLL) is not well understood. We hypothesized that the…”
Get full text
Journal Article -
20
Novel Germline Genetic Variants Associated with Familial Chronic Lymphocytic Leukemia (CLL)
Published in Blood (18-11-2011)“…Abstract 465 CLL is among the most heritable of all cancers. To understand the genetic basis of this heritability, we have undertaken a comprehensive genomic…”
Get full text
Journal Article